81 related articles for article (PubMed ID: 9362203)
1. Effect of octreotide on gastrostomy, duodenostomy, and cholecystostomy effluents: a physiologic study of fluid and electrolyte balance.
Niv Y; Charash B; Sperber AD; Oren M
Am J Gastroenterol; 1997 Nov; 92(11):2107-11. PubMed ID: 9362203
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and beta-endorphin levels.
Befon S; Mystakidou K; Lyra M; Tubanakis N; Vlahos L
Anticancer Res; 2000; 20(5C):4039-46. PubMed ID: 11268498
[TBL] [Abstract][Full Text] [Related]
3. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.
Jenkins SA; Nott DM; Baxter JN
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):255-8. PubMed ID: 7743308
[TBL] [Abstract][Full Text] [Related]
4. The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated Endoscopic Pancreatic Function Test (ePFT).
Conwell DL; Zuccaro G; Purich E; Fein S; Vanlente F; Vargo J; Dumot J; O'laughlin C; Trolli P
Am J Gastroenterol; 2005 May; 100(5):1161-6. PubMed ID: 15842594
[TBL] [Abstract][Full Text] [Related]
5. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
[TBL] [Abstract][Full Text] [Related]
6. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
[TBL] [Abstract][Full Text] [Related]
7. Gastroduodenostomy after gastric resection for cancer.
Kim BJ; O'Connell T
Am Surg; 1999 Oct; 65(10):905-7. PubMed ID: 10515531
[TBL] [Abstract][Full Text] [Related]
8. Effect of the somatostatin analogue octreotide on gastric fluid pH in ponies.
Sojka JE; Weiss JS; Samuels ML; You GM
Am J Vet Res; 1992 Oct; 53(10):1818-21. PubMed ID: 1456527
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
10. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
Vorobioff JD; Ferretti SE; Zangroniz P; Gamen M; Picabea E; Bessone FO; Reggiardo V; Diez AR; Tanno M; Cuesta C; Tanno HE
Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
[TBL] [Abstract][Full Text] [Related]
11. Octreotide in the treatment of thoracic duct injuries.
Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
13. Octreotide: a therapeutic option for idiopathic intracranial hypertension.
Panagopoulos GN; Deftereos SN; Tagaris GA; Gryllia M; Kounadi T; Karamani O; Panagiotidis D; Koutiola-Pappa E; Karageorgiou CE; Piadites G
Neurol Neurophysiol Neurosci; 2007 Jul; ():1. PubMed ID: 17700925
[TBL] [Abstract][Full Text] [Related]
14. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
[TBL] [Abstract][Full Text] [Related]
15. Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
Turner HE; Thornton-Jones VA; Wass JA
Clin Endocrinol (Oxf); 2004 Aug; 61(2):224-31. PubMed ID: 15272918
[TBL] [Abstract][Full Text] [Related]
16. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia.
Scaglione G; Pietrini L; Russo F; Franco MR; Sorrentini I
Aliment Pharmacol Ther; 2007 Sep; 26(6):935-42. PubMed ID: 17767478
[TBL] [Abstract][Full Text] [Related]
17. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
19. High dose octreotide in the management of acute pancreatitis.
Karakoyunlar O; Sivrel E; Tanir N; Deneçli AG
Hepatogastroenterology; 1999; 46(27):1968-72. PubMed ID: 10430379
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome.
Klooker TK; Kuiken SD; Lei A; Boeckxstaens GE
Aliment Pharmacol Ther; 2007 Aug; 26(4):605-15. PubMed ID: 17661764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
